How to Read a Male Vitality Supplement Label: Proprietary Blends, Blend Maths and the Doses That Vanish

The one rule that hands you free information

Most articles about proprietary blends tell you that blends hide amounts and then stop. What matters is the part of the regulation that does work in your favour.

Under 21 CFR 101.36, the US rule governing Supplement Facts panels, two things are mandatory. First, the quantitative amount by weight declared for a proprietary blend must be the total weight of all the dietary ingredients in it, printed on the same line as the blend name. Second, the ingredients inside that blend must be declared in descending order of predominance by weight, indented underneath the blend name.

The second rule is the whole game. The manufacturer does not have to tell you the amounts, but it does have to tell you the ranking: first-named is heaviest, last-named is lightest. That is a legally binding statement about your product, printed on the box, and almost nobody uses it. If you are buying a formula specifically for its Tongkat Ali and Tongkat Ali is listed third of three, you already know it is the smallest component of that blend before you do any arithmetic at all.

Blend maths: the arithmetic that ends the argument

Here is the calculation nobody in this category publishes. Take the blend total. Divide it by the number of ingredients named inside the blend. That figure is the maximum the smallest-listed ingredient can be, because a perfectly even split is the best possible case and any uneven split makes the smallest one smaller.

Then compare that ceiling against the dose the trials actually used. If the ceiling is already lower, you are done. No further information is required and no marketing copy can rescue it.

Table A — Blend maths, worked

Blend total	Ingredients named	Max possible for smallest-listed	Studied dose to clear	Verdict
870 mg	3 botanicals	290 mg	Tongkat Ali 100–400 mg/day	Arithmetically possible — an even split clears the trial range, but the panel does not state the split
870 mg	3 botanicals	290 mg	Saw palmetto 320 mg/day	Impossible if listed last. 320 mg is more than a third of 870 mg, so saw palmetto at its studied dose would have to be the largest component
1,200 mg	6 ingredients	200 mg	Tribulus 400–750 mg/day	Impossible for the smallest-listed — the ceiling is half the low end of the studied range
1,500 mg	10 ingredients	150 mg	Saw palmetto 320 mg/day	Impossible for the smallest-listed, and impossible for most of the others too
500 mg	8 ingredients	62.5 mg	Tongkat Ali 100–400 mg/day	Impossible for the smallest-listed — below even the lowest trialled dose

The 870 mg row shows how the test cuts both ways. Three botanicals in 870 mg is a comparatively tight blend, and an even three-way split of 290 mg each would comfortably clear the Tongkat Ali trial range. But an even split is an assumption, not a disclosure. Because the ordering rule guarantees the third-listed botanical is the lightest, the honest reading is that one of those three is above 290 mg and one is below it, and the panel does not tell you by how much.

What the trials actually dosed

The ceiling test only works if you know what you are measuring against. These are the doses used in the published human research for the three botanicals men most often meet on a male-vitality label. Every figure below comes from a primary source, not a supplement blog. For the Tongkat Ali row specifically, our study-by-study breakdown of what the trials actually dosed goes through each trial in turn.

Table B — Studied dose lookup

Ingredient	Dose used in trials	Standardisation that mattered	Source
Tongkat Ali (Eurycoma longifolia)	100–400 mg/day; 200 mg the most frequently trialled	Standardised aqueous root extract. The clinical Physta extract is specified at 0.8–1.5% eurycomanone, with defined protein, polysaccharide and glycosaponin fractions	Leisegang K et al., Medicina 2022;58(8):1047; Talbott SM et al., J Int Soc Sports Nutr 2013;10:28; Chinnappan SM et al., Food & Nutrition Research 2021;65:5647
Tribulus terrestris	400–750 mg/day for one to three months	No single clinical standard. Steroidal saponin content varies widely between preparations and is rarely stated	Vilar Neto JO et al., Nutrients 2025;17(7):1275 — 10 studies, 483 participants
Saw palmetto	320 mg/day as the standard dose; escalated to 640 mg and then 960 mg in the CAMUS trial	Lipidosterolic fruit extract. The dose escalation ran 320 mg to week 24, 640 mg to week 48, 960 mg to week 72	Barry MJ et al., JAMA 2011;306(12):1344–51 — 369 men aged 45 and over

Two of those rows carry an important caveat that the dose figure alone does not convey. For Tribulus, the systematic review that produced the 400–750 mg range concluded that no robust evidence was found for increasing testosterone levels — eight of its ten studies reported no significant androgen change. Hitting the studied dose of an ingredient whose studies were negative buys you nothing. And for saw palmetto, the CAMUS trial found no advantage over placebo on its primary outcome even at three times the usual dose, so 320 mg is a benchmark for comparability, not a promise.

That distinction — dose adequacy versus evidence quality — is why we treat these as two separate checks. Our evidence review of Tongkat Ali, Tribulus and saw palmetto covers the second one in detail.

Label red flags, and the seals that actually mean something

Once you can do the arithmetic, most of the remaining tricks become easy to spot. These are the ones worth knowing.

Third-party certification is the one genuine quality signal available to a consumer, and it is also routinely oversold. USP Verified, NSF Certified for Sport and Informed Sport all test finished products for identity, contamination and, in the sport programmes, banned substances. That is real and it is worth paying for.

But note two things. First, none of those programmes certifies that a dose is clinically meaningful. They confirm that what is on the label is in the bottle, which is a different and lower bar than confirming the label describes a useful amount. Second, the logo itself is not the proof. The US Anti-Doping Agency's guidance on NSF Certified for Sport is explicit that you should confirm the lot number on the bottle in front of you matches the lot listed in the certifier's own database. Artwork can be printed by anyone. A lot entry cannot.

Applying this to Primordial Vigor X

We publish this site as an affiliate, so it would be easy to write a label guide that quietly exempts our own product. Primordial Vigor X publishes an 870 mg once-daily total and names three botanicals: Tribulus terrestris, Tongkat Ali (Eurycoma longifolia) root and saw palmetto berry. What we have not been able to verify anywhere is a published per-ingredient milligram breakdown, or a standardisation figure for any of the three. The homepage says as much. That means the same limitation described in Table A applies here: the blend total is disclosed, the split is not, and no reader can map 870 mg onto any row of Table B.

The practical instruction is therefore the same one we would give for any competing formula. Before you buy, open the Supplement Facts panel on the official store and look for exactly three lines: the blend total, the order the three botanicals are listed in, and whether any standardisation percentage is printed next to the Tongkat Ali entry. Those three lines tell you more than the entire front of the box. If a standardisation figure is present, our guide to what eurycomanone percentages and extract ratios actually mean explains how to read it.

What this method does not show

Blend arithmetic is a screening tool with real limits, and it is worth being clear about them.

It can prove an ingredient is below a studied dose. It can never prove one is at a studied dose, because the ceiling test only ever produces an upper bound. A blend that passes has not been shown to be adequately dosed; it has only failed to be shown inadequate.

It says nothing about extract quality: two products can declare the same milligrams of the same botanical and contain very different amounts of the compound the trials were measuring. It says nothing about whether the ingredient works — a correctly dosed ingredient with negative trial evidence is still negative, which is the situation Tribulus is in. And it says nothing about the finished product, because a multi-ingredient supplement has almost never been trialled as sold. Evidence attaches to the ingredients, at their doses, in their standardisations — not to the bottle.

Finally, the scale of the gap between claim and evidence in this category is documented. A 2020 analysis in the World Journal of Men's Health examined 50 top-selling testosterone-boosting supplements containing 109 distinct compounds. Ninety per cent of the products claimed to boost testosterone. Only 24.8% of the compounds had data supporting that claim, 18.3% had data showing no change, and 10.1% contained components with data suggesting a negative effect. Reading the panel properly is not pedantry. It is the only defence available.

Frequently asked questions